Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CAPR stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CAPR investment potential.

What is CAPR stock price today?

Get real-time CAPR stock price, historical data, and price charts on Financhill. Track CAPR performance with our advanced analysis tools.

Is CAPR a good investment?

Evaluate CAPR investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CAPR stock?

To buy CAPR stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CAPR?

View detailed market capitalization data and company valuation metrics for CAPR on our comprehensive analysis page.

What is the P/E ratio of CAPR?

Use our fundamental analysis tools to view CAPR P/E ratio and compare valuation metrics with industry peers.

What are CAPR earnings?

View CAPR earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Capricor Therapeutics, Inc. Stock Predictions

Color-coded buy, sell, hold signals make stock decisions simple.

Get Your Free Stock Analysis Now

Buy

CAPR
Capricor Therapeutics, Inc.

Last Price:

$21.89

Seasonality Move:

12.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Know when to buy, sell, or hold. Rate Any Stock In Seconds

Get Your Free Stock Analysis Now

Capricor Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Capricor Therapeutics, Inc. has on average historically risen by 8.9% based on the past 23 years of stock performance.
Capricor Therapeutics, Inc. has risen higher in 9 of those 23 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.13%
Is Capricor Therapeutics, Inc. Stock Undervalued?

The current Capricor Therapeutics, Inc. [CAPR] share price is $21.89. The Score for CAPR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
CAPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Capricor Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Capricor Therapeutics, Inc. has on average historically risen by 8.9% based on the past 23 years of stock performance.

Capricor Therapeutics, Inc. Stock Rating

Buy

Capricor Therapeutics, Inc. (CAPR) is a Buy

Is Capricor Therapeutics, Inc. overpriced?

Capricor Therapeutics, Inc. has risen higher in 9 of those 23 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.13%

Capricor Therapeutics, Inc. Stock Price History

Is CAPR stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAPR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

capricor.com

52-Week Data

52-Week High:

40.37

52-Week Low:

4.30

Prediction Charts

Market Cap:

Price in USD:

21.89

Volume:

972.9K

Beta:

2.00

Technical Analysis

SMA50:

21.09

SMA100:

13.83

SMA200:

11.59

52-Wk Change:

44.01%

Stock Predictions

Is Capricor Therapeutics, Inc. stock public?

Yes, Capricor Therapeutics, Inc. is a publicly traded company.
What is the Capricor Therapeutics, Inc. stock quote today?

The Capricor Therapeutics, Inc. stock price is 21.89 USD today.
How to buy Capricor Therapeutics, Inc. stock online?

You can buy Capricor Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-12	23.62	24.51	24.86	23.24
Jan-13	24.27	24.79	25.44	24.12
Jan-14	24.51	24.79	25.00	24.23
Jan-15	24.68	24.04	24.69	23.53
Jan-16	24.16	24.35	24.89	23.96
Jan-20	25.38	24.20	25.70	23.58
Jan-21	23.91	24.31	24.62	23.52
Jan-22	24.34	24.17	24.74	24.09
Jan-23	24.02	23.20	24.14	23.01
Jan-26	23.03	23.62	23.71	22.80
Jan-27	23.69	23.52	23.75	23.10
Jan-28	23.86	21.57	23.86	21.40
Jan-29	21.61	22.61	22.70	21.06
Jan-30	22.70	21.89	23.00	21.83

Capricor Therapeutics, Inc. Earnings

Capricor Therapeutics, Inc. Earnings Report: Per Share Capricor Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Capricor Therapeutics, Inc. Forecast Revenue Growth

Capricor Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Capricor Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.31 per share, and a decrease next year of $0.08 per share.

* Capricor Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.